Replies to post #254797 on NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Gary, I believe that between the main arm of 331 blinded patients and the companion arms, NWBO will be able to provide the FDA with enough statistics.

I don't believe that even with maximum resections and 5-ALA, SOC alone could obtain the impressive survival results that we have been observing.

Time will tell but it is my hunch that we have a winner here and that DCVax-L will be approved without additional trials.